Treatment Outcomes and Risk Factors for Incomplete Treatment after Definitive Chemoradiotherapy for Non-Resectable or Metastatic Esophageal Cancer

SIMPLE SUMMARY: The rates of adverse events and incomplete treatment remain high among patients with unresectable or metastatic esophageal cancer who receive definitive treatment. The overall survival and treatment-related adverse events were analyzed. Subgroup analysis was performed based on the co...

Descripción completa

Detalles Bibliográficos
Autores principales: Pai, Chu-Pin, Chien, Ling-I, Huang, Chien-Sheng, Hsu, Han-Shui, Hsu, Po-Kuei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10670551/
https://www.ncbi.nlm.nih.gov/pubmed/38001681
http://dx.doi.org/10.3390/cancers15225421

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10670551/
https://www.ncbi.nlm.nih.gov/pubmed/38001681
http://dx.doi.org/10.3390/cancers15225421

Ejemplares similares